Generic substitution for immunosuppressi
β
J. Harold Helderman
π
Article
π
2011
π
Wiley (John Wiley & Sons)
π
English
β 137 KB
## Abstract The advent of generic alternatives for transplant immunosuppressant drugs has engendered concern and discussion. The process by which the food and drug administration (FDA) approves generic substitutes is reviewed. A category of medicines deο¬ned as narrow therapeutic index (NTI) drugs i